SCHEMBL29655176

SCHEMBL29655176

C[C@@H](O)C(=O)NCCc1ccc(O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.64
F13A1 P00488 1/20 0.64
ESRRG P62508 3/20 0.55
ESRRB O95718 2/20 0.55
GLI1 P08151 1/20 0.53
GLI2 P10070 1/20 0.53
TMEM97 Q5BJF2 2/20 0.52
SIGMAR1 Q99720 2/20 0.52
ADRB2 P07550 2/20 0.51
LMNA P02545 2/20 0.51
CYP2D6 P10635 2/20 0.51
HIF1A Q16665 2/20 0.51
SLC6A2 P23975 2/20 0.51
SLC6A4 P31645 2/20 0.51
OPRM1 P35372 2/20 0.51
GALR3 O60755 1/20 0.51
ADRB1 P08588 1/20 0.51
ADRA1A P35348 1/20 0.51
OPRK1 P41145 1/20 0.51
SLC6A3 Q01959 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5060920 1.00 KDM4E (0.64) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL4949918 1.00 KDM4E (0.64) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL12164125 0.88 KDM4E (0.66) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL11135700 0.85 KDM4E (0.62) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL31126659 0.84 KMT2A (0.63) CYP2D6NPC1MAPTCYP2C19RAB9A
SCHEMBL2733102 0.84 KDM4E (0.57) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL18324609 0.83 GAA (0.68) KDM4EF13A1ESRRGESRRBGLI1
Hydrochloric Acid SCHEMBL11140134 0.83 KDM4E (0.60) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL10044110 0.83 KDM4E (0.55) KDM4EF13A1ESRRGESRRBGLI1
SCHEMBL4948472 0.82 ERCC1 (0.51) KDM4EF13A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 KDM4E 3699/4885F13A1 3546/4885ESRRG 3018/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 KDM4E 3699/4885F13A1 3546/4885ESRRG 3018/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 KDM4E 3699/4885F13A1 3546/4885ESRRG 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.